# A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

> **NCT01052779** · PHASE2 · COMPLETED · sponsor: **AMAG Pharmaceuticals, Inc.** · enrollment: 162 (actual)

## Conditions studied

- Iron Deficiency
- Anemia
- Kidney Disease

## Interventions

- **DRUG:** Ferumoxytol
- **DRUG:** Iron Sucrose

## Key facts

- **NCT ID:** NCT01052779
- **Lead sponsor:** AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-01
- **Primary completion:** 2011-07-19
- **Final completion:** 2012-04-19
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052779, "A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01052779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*